Real-life data of immune recovery using bictegravir/emtricitabine/ tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48–96 weeks of RETROBIC Study

  1. Troya, J.
  2. Pousada, G.
  3. Micán, R.
  4. Galera, C.
  5. Sanz, J.
  6. de los Santos, I.
  7. Dueñas, C.
  8. Cabello, N.
  9. Martín, C.
  10. Galindo, M.J.
  11. Garcinuño, M.Á.
  12. Pedrero-Tomé, R.
  13. Buzón, L.
Journal:
Journal of Antimicrobial Chemotherapy

ISSN: 1460-2091 0305-7453

Year of publication: 2024

Volume: 79

Issue: 3

Pages: 595-607

Type: Article

DOI: 10.1093/JAC/DKAE011 GOOGLE SCHOLAR

Sustainable development goals